The estimated Net Worth of Bruce Gerhardt is at least $31.9 mil dollars as of 19 October 2016. Mr. Gerhardt owns over 50,000 units of Biocept Inc stock worth over $31,880 and over the last 11 years he sold BIOC stock worth over $0. In addition, he makes $0 as Independent Director at Biocept Inc.
Sign up
Mr. Gerhardt BIOC stock SEC Form 4 insiders trading
Bruce has made over 3 trades of the Biocept Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 50,000 units of BIOC stock worth $55,000 on 19 October 2016.
The largest trade he's ever made was buying 50,000 units of Biocept Inc stock on 19 October 2016 worth over $55,000. On average, Bruce trades about 6,333 units every 41 days since 2014. As of 19 October 2016 he still owns at least 73,304 units of Biocept Inc stock.
You can see the complete history of Mr. Gerhardt stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Bruce Gerhardt biography
Bruce E. Gerhardt CPA serves as Independent Director of the Company. Mr. Gerhardt has been self-employed, practicing as a Certified Public Accountant, since 1986. He is also a tax and business advisor providing tax compliance for small businesses and upper income individuals. Prior to 1986, he was a financial vice-president with several companies and a senior accountant with Peat Marwick Mitchell, now KPMG, one of the “Big Four” accounting firms. He earned his Bachelor of Arts Degree from the University of Southern California in 1973 and is a member of the American Institute of Certified Public Accountants. We selected Mr. Gerhardt to serve on our board of directors due to his experience and expertise in financial accounting and auditing. Mr. Gerhardt also serves as a member of our audit committee and as a member of our compensation committee.
How old is Bruce Gerhardt?
Bruce Gerhardt is 69, he's been the Independent Director of Biocept Inc since 2010. There are 6 older and 12 younger executives at Biocept Inc. The oldest executive at Biocept Inc is Margaret Faye Wilson, 82, who is the Lead Independent Director.
What's Bruce Gerhardt's mailing address?
Bruce's mailing address filed with the SEC is C/O BIOCEPT, INC., 9955 MESA RIM ROAD, SAN DIEGO, CA, 92121.
Insiders trading at Biocept Inc
Over the last 11 years, insiders at Biocept Inc have traded over $2,456 worth of Biocept Inc stock and bought 1,703,300 units worth $1,869,312 . The most active insiders traders include Claire Reiss, Edward A. Neff, eDavid F Hale. On average, Biocept Inc executives and independent directors trade stock every 92 days with the average trade being worth of $27,462. The most recent stock trade was executed by David F Hale on 9 December 2021, trading 445 units of BIOC stock currently worth $1,807.
What does Biocept Inc do?
biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor associated dna , both in circulating tumor cells (ctcs) and in plasma (cell free circulating tumor dna). our mission is to improve outcomes for cancer patients by advancing oncology diagnostics. we utilize patented and innovative technologies to deliver clinically relevant oncology diagnostics to physicians by providing advanced prognostic and predictive assessments for guiding the course of treating patients. additionally, we offer services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies, and clinical trial support. our strategic focus is to promote our unique targeted selector™ technology to the oncology community. our target selector technology has demonstrated that it can consistently capture extremely rare cells which may be present in only 1 of every 50-100 billion blood cells. examples of these rare cells ar
What does Biocept Inc's logo look like?
Complete history of Mr. Gerhardt stock trades at Biocept Inc
Biocept Inc executives and stock owners
Biocept Inc executives and other stock owners filed with the SEC include:
-
Michael Nall,
President, Chief Executive Officer, Director -
Timothy Kennedy,
Chief Financial Officer, Senior Vice President - Operations, Corporate Secretary -
Michael Terry,
Sr. VP of Corp. Devel. -
Lyle Arnold,
Senior Vice President - Research & Development, Chief Scientific Officer -
David Hale,
Non-Executive Chairman of the Board -
Samuel D. Riccitelli,
Interim Pres & CEO and Independent Chairman -
Margaret Faye Wilson,
Lead Independent Director -
Ivor Royston,
Independent Director -
Bruce Huebner,
Independent Director -
Bruce Gerhardt,
Independent Director -
Marsha Chandler,
Independent Director -
Samuel Riccitelli,
Director -
Michael Terry,
Senior Vice President - Corporate Development -
Cory Dunn,
Senior Vice President of Commercial Operations -
Antonio Paternostro,
VP of Sales -
Dr. Philippe J. Marchand Ph.D.,
Chief Operating Officer -
Dr. Michael C. Dugan M.D.,
Sr. VP, Chief Medical Officer & Medical Director -
Dr. Veena M. Singh,
Sr. Medical Director -
David S. Moskowitz R.Ph., MBA,
VP of Strategy & Corp. Communications -
Darrell Taylor Esq.,
Sr. VP, Chief Legal Officer & Chief Compliance Officer -
Dr. Lyle J. Arnold Ph.D.,
Chief Scientist & Member of Scientific Advisory Board -
Pavel Tsinberg,
Director of Technology Devel. -
Antonino Morales,
Interim CFO & Director -
Dr. Soon Kap Hahn Ph.D.,
Founder -
Quyen Thi Dao Haddock,
Director -
Bridge Lb Healthcare Master...,
-
Edward A. Neff,
Director -
Veena Singh,
Sr VP & Sr Med Director -
Claire Reiss,
10% owner -
Linda M Rubinstein,
Director -
Raaj Trivedi,
VP, COMMERCIAL OPERATIONS -
Mark G Foletta,
Interim CFO -
Philippe Marchand,
Chief Operations Officer -
William G Kachioff,
SVP, CFO AND SECRETARY -
Farideh Z. Bischoff,
VICE PRESIDENT -
Darrell Taylor,
See remarks -
Michael C Dugan,
Chief Med Off & Med. Director -
Antonino Morales,
Interim CFO